Thus, the finding that Ano1 overexpression was associated with poor prognosis in breast cancer patients with 11q13 amplification in the study by Britschgi et al. [15] suggests that Ano1 overexpression is a prognostic factor for this specific population of breast cancer. The gene discussed is ANO1; the disease is breast cancer.